Compare IZM & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IZM | PPCB |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | China | Australia |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3M | 2.6M |
| IPO Year | 2021 | 2011 |
| Metric | IZM | PPCB |
|---|---|---|
| Price | $0.95 | $0.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 156.4K |
| Earning Date | 10-27-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.39 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.21 | $0.06 |
| 52 Week High | $2.73 | $6.79 |
| Indicator | IZM | PPCB |
|---|---|---|
| Relative Strength Index (RSI) | 51.14 | 28.71 |
| Support Level | $0.28 | $0.17 |
| Resistance Level | $1.46 | $0.40 |
| Average True Range (ATR) | 0.19 | 0.05 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 11.56 | 6.67 |
ICZOOM Group Inc. operates an e-commerce platform selling electronic components to SMEs in China across consumer electronics, IoT, automotive, and industrial control sectors. It offers two main product categories: semiconductor products, including integrated circuits and optoelectronics, and electronic equipment and tools such as electromechanical and MRO supplies. The company also provides services like customs clearance, temporary warehousing, and logistics, earning additional commission fees. The majority of its revenue comes from electronic component sales.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.